Dunn Edmund - Insider Non-Derivative Transactions at Monte Rosa Therapeutics, Inc. (GLUE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 3, 2025, Dunn Edmund's relationship to Monte Rosa Therapeutics, Inc. (GLUE) is Officer (Principal Accounting Officer), and currently has 23,732 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other GLUE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Dunn Edmund - Insider Non-Derivative Transactions of GLUE Common Stock

Dunn Edmund - Insider Non-Derivative Transactions at GLUE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 4, 2025	Sell -- (Common Stock)	2062	4.45	23732
Jan 3, 2025	Acquisition -- (Common Stock)	11850	0	25794
Jul 6, 2024	Sell -- (Common Stock)	1610	3.83	13944
Jun 4, 2024	Sell -- (Common Stock)	1207	4.04	15554